{
    "clinical_study": {
        "@rank": "110840", 
        "arm_group": [
            {
                "arm_group_label": "Sufentanil NanoTab Single Dose", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Sufentanil NanoTab Multiple Dose", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "determine the plasma concentration profile after single and multiple dosing of Sufentanil\n      NanoTabs"
        }, 
        "brief_title": "Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTab", 
        "condition": "Plasma Concentrations", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  non smokers\n\n        Exclusion Criteria:\n\n          -  pregnant or breastfeeding women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "January 3, 2013", 
        "id_info": {
            "nct_id": "NCT01761565", 
            "org_study_id": "IAP101"
        }, 
        "intervention": {
            "arm_group_label": [
                "Sufentanil NanoTab Single Dose", 
                "Sufentanil NanoTab Multiple Dose"
            ], 
            "intervention_name": "Sufentanil", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Sufentanil"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "October 4, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Lenexa", 
                    "country": "United States", 
                    "state": "Kansas", 
                    "zip": "66219"
                }, 
                "name": "PRA"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Single- and Multiple-Dose Pharmacokinetics of Sublingual Sufentanil NanoTab\u00ae PCA System in Healthy Subjects", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "plasma concentration", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01761565"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "AcelRx Pharmaceuticals, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AcelRx Pharmaceuticals, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}